Title : Dexmedetomidine attenuates acute kidney injury in children undergoing congenital heart surgery with cardiopulmonary bypass by inhibiting the TLR3/NF-κB signaling pathway.

Pub. Date : 2021

PMID : 34017439






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dexmedetomidine attenuates acute kidney injury in children undergoing congenital heart surgery with cardiopulmonary bypass by inhibiting the TLR3/NF-kappaB signaling pathway. Dexmedetomidine nuclear factor kappa B subunit 1 Homo sapiens
2 Compared with the controls, the DMED group had lower levels of NF-kappaB and TLR3 at T2-T4, lower levels of sCr, IL-1beta, and TNF-alpha at T3-T4, and lower incidence of AKI at T3 (all P<=0.01). Dexmedetomidine nuclear factor kappa B subunit 1 Homo sapiens
3 CONCLUSION: DMED can reduce the risk of AKI in children undergoing CHS with CPB, which may be because DMED can inhibit TLR3/NF-kappaB signaling and its downstream inflammatory mediators. Dexmedetomidine nuclear factor kappa B subunit 1 Homo sapiens
4 CONCLUSION: DMED can reduce the risk of AKI in children undergoing CHS with CPB, which may be because DMED can inhibit TLR3/NF-kappaB signaling and its downstream inflammatory mediators. Dexmedetomidine nuclear factor kappa B subunit 1 Homo sapiens